Avenues Within the Gut-liver-brain Axis Linking Chronic Liver Disease and Symptoms

Overview

Journal Front Neurosci

Date 2023 Jul 31

PMID 37521690

Authors

Henry H Nguyen

Mark G Swain

Affiliations

Soon will be listed here.

Abstract

Symptoms of fatigue, social withdrawal and mood disturbances are commonly encountered in patients with chronic liver disease and have a detrimental effect on patient quality of life. Treatment options for these symptoms are limited and a current area of unmet medical need. In this review, we will evaluate the potential mechanistic avenues within the gut-liver-brain axis that may be altered in the setting of chronic liver disease that drive the development of these symptoms. Both clinical and pre-clinical studies will be highlighted as we discuss how perturbations in host immune response, microbiome, neural responses, and metabolites composition can affect the central nervous system.

Citing Articles

Interaction between Per- and Polyfluorinated Substances (PFAS) and Acetaminophen in Disease Exacerbation-Focusing on Autism and the Gut-Liver-Brain Axis.

Jiang D, Guo T Toxics. 2024; 12(1).

PMID: 38250995 PMC: 10818890. DOI: 10.3390/toxics12010039.

The Gut-Liver-Brain Axis: From the Head to the Feet.

Giuffre M, Moretti R Int J Mol Sci. 2023; 24(21).

PMID: 37958647 PMC: 10649143. DOI: 10.3390/ijms242115662.

References

Abdel-Haq R, Schlachetzki J, Glass C, Mazmanian S . Microbiome-microglia connections via the gut-brain axis. J Exp Med. 2018; 216(1):41-59. PMC: 6314531. DOI: 10.1084/jem.20180794. View

Mells G, Pells G, Newton J, Bathgate A, Burroughs A, Heneghan M . Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology. 2013; 58(1):273-83. DOI: 10.1002/hep.26365. View

Wu W, Kang K, Chen S, Chiu S, Yen A, Fann J . Hepatitis C virus infection: a risk factor for Parkinson's disease. J Viral Hepat. 2015; 22(10):784-91. DOI: 10.1111/jvh.12392. View

Reichardt J, Dirks M, Wirries A, Pflugrad H, Nosel P, Haag K . Brain metabolic and microstructural alterations associated with hepatitis C virus infection, autoimmune hepatitis and primary biliary cholangitis. Liver Int. 2021; 42(4):842-852. DOI: 10.1111/liv.15093. View

Klos K, Ahlskog J, Kumar N, Cambern S, Butz J, Burritt M . Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity. Neurology. 2006; 67(11):1984-9. DOI: 10.1212/01.wnl.0000247037.37807.76. View

Zenouzi R, von der Gablentz J, Heldmann M, Gottlich M, Weiler-Normann C, Sebode M . Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal attention performance and brain structure. PLoS One. 2018; 13(1):e0190005. PMC: 5761833. DOI: 10.1371/journal.pone.0190005. View

Ding J, Jin Z, Yang X, Lou J, Shan W, Hu Y . Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World J Gastroenterol. 2020; 26(40):6141-6162. PMC: 7596643. DOI: 10.3748/wjg.v26.i40.6141. View

Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A . Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metab. 2017; 25(5):1054-1062.e5. PMC: 5502730. DOI: 10.1016/j.cmet.2017.04.001. View

Newton J, Hollingsworth K, Taylor R, El-Sharkawy A, Khan Z, Pearce R . Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology. Hepatology. 2008; 48(2):541-9. DOI: 10.1002/hep.22371. View

10.

Nohr M, Egerod K, Christiansen S, Gille A, Offermanns S, Schwartz T . Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience. 2015; 290:126-37. DOI: 10.1016/j.neuroscience.2015.01.040. View

11.

Cryan J, ORiordan K, Sandhu K, Peterson V, Dinan T . The gut microbiome in neurological disorders. Lancet Neurol. 2019; 19(2):179-194. DOI: 10.1016/S1474-4422(19)30356-4. View

12.

Schilsky M, Roberts E, Bronstein J, Dhawan A, Hamilton J, Rivard A . A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. 2022; . DOI: 10.1002/hep.32801. View

13.

Mizuno K, Ueno Y . Autonomic Nervous System and the Liver. Hepatol Res. 2016; 47(2):160-165. DOI: 10.1111/hepr.12760. View

14.

DMello C, Swain M . Liver-brain interactions in inflammatory liver diseases: implications for fatigue and mood disorders. Brain Behav Immun. 2013; 35:9-20. DOI: 10.1016/j.bbi.2013.10.009. View

15.

Barbosa M, Zaninotto A, Mazo D, Pessoa M, de Oliveira C, Carrilho F . Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin. BMC Gastroenterol. 2017; 17(1):122. PMC: 5702148. DOI: 10.1186/s12876-017-0679-5. View

16.

Seo S, Gottesman R, Clark J, Hernaez R, Chang Y, Kim C . Nonalcoholic fatty liver disease is associated with cognitive function in adults. Neurology. 2016; 86(12):1136-42. PMC: 4820136. DOI: 10.1212/WNL.0000000000002498. View

17.

Moretti R, Caruso P, Gazzin S . Non-alcoholic fatty liver disease and neurological defects. Ann Hepatol. 2019; 18(4):563-570. DOI: 10.1016/j.aohep.2019.04.007. View

18.

Zheng D, Liwinski T, Elinav E . Interaction between microbiota and immunity in health and disease. Cell Res. 2020; 30(6):492-506. PMC: 7264227. DOI: 10.1038/s41422-020-0332-7. View

19.

Nucera S, Ruga S, Cardamone A, Coppoletta A, Guarnieri L, Zito M . MAFLD progression contributes to altered thalamus metabolism and brain structure. Sci Rep. 2022; 12(1):1207. PMC: 8786899. DOI: 10.1038/s41598-022-05228-5. View

20.

Tan C, Chang M, Tsai W, Chuang W, Huang J, Lin Z . Different profiles of neurocognitive impairment in patients with hepatitis B and C virus infections. Sci Rep. 2022; 12(1):10625. PMC: 9226189. DOI: 10.1038/s41598-022-14736-3. View